Literature DB >> 6308271

Mitochondrial function in canine experimental cardiac hypertrophy.

M A Matlib, J C Rembert, R W Millard, M Ashraf, W Rouslin, G Asano, J C Greenfield, A Schwartz.   

Abstract

Concentric left ventricular hypertrophy was produced in puppies by coarctation banding of the aorta at age 7 weeks. Hemodynamic, morphologic and biochemical studies were carried out 18 months after the operation. Systolic blood pressure proximal to the aortic constriction was 216 +/- 16 mmHg in experimental dogs compared with 115 +/- 5 mmHg in littermate control dogs. Ejection fraction of control and experimental dogs were 59 +/- 4 and 64 +/- 7, respectively. The left ventricular end-diastolic pressure was 6.0 +/- 0.4 in control and 8.4 +/- 1.1 in experimental dogs. There was no sign of overt heart failure in the experimental dogs. Anatomical analysis of different regions of the heart indicated that LV mass in the experimental dogs was increased by about 60%. Ultrastructure of mitochondria in situ, as observed under electron microscope, was normal both in control and hypertrophic hearts. Mitochondria isolated from epicardial and endocardial regions of the stable hypertrophic hearts showed normal rates of respiration, phosphorylation, citrate synthase, and cytochrome c oxidase activities compared to those isolated from hearts of littermate control dogs. It was, therefore, concluded that mitochondrial function is adequately preserved to meet the increased demand for energy in this model of stable cardiac hypertrophy of long duration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6308271     DOI: 10.1016/0022-2828(83)90277-8

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  4 in total

1.  Mitochondrial depolarization and electrophysiological changes during ischemia in the rabbit and human heart.

Authors:  Matthew S Sulkin; Bas J Boukens; Megan Tetlow; Sarah R Gutbrod; Fu Siong Ng; Igor R Efimov
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-15       Impact factor: 4.733

2.  Mitochondrial dysfunction in uremic cardiomyopathy.

Authors:  David Taylor; Sunil Bhandari; Anne-Marie L Seymour
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

Review 3.  Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.

Authors:  Brian O'Rourke; Jennifer E Van Eyk; D Brian Foster
Journal:  Congest Heart Fail       Date:  2011-11-09

Review 4.  Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.

Authors:  E Dale Abel; Torsten Doenst
Journal:  Cardiovasc Res       Date:  2011-01-21       Impact factor: 10.787

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.